|Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance …|
E Bonora, G Targher, M Alberiche, RC Bonadonna, F Saggiani, ...
Diabetes care 23 (1), 57-63, 2000
|Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease|
G Targher, CP Day, E Bonora
New England Journal of Medicine 363 (14), 1341-1350, 2010
|NAFLD: a multisystem disease|
CD Byrne, G Targher
Journal of hepatology 62 (1), S47-S64, 2015
|Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis|
QM Anstee, G Targher, CP Day
Nature reviews Gastroenterology & hepatology 10 (6), 330, 2013
|Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.|
E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, ...
Diabetes 47 (10), 1643-1649, 1998
|Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients|
G Targher, L Bertolini, R Padovani, S Rodella, R Tessari, L Zenari, C Day, ...
Diabetes care 30 (5), 1212-1218, 2007
|Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients|
G Lippi, G Targher, M Montagnana, GL Salvagno, G Zoppini, GC Guidi
Archives of pathology & laboratory medicine 133 (4), 628-632, 2009
|Non-alcoholic fatty liver disease and increased risk of cardiovascular disease|
G Targher, G Arcaro
Atherosclerosis 191 (2), 235-240, 2007
|Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients|
G Targher, L Bertolini, F Poli, S Rodella, L Scala, R Tessari, L Zenari, ...
Diabetes 54 (12), 3541-3546, 2005
|Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis|
G Targher, CD Byrne, A Lonardo, G Zoppini, C Barbui
Journal of hepatology 65 (3), 589-600, 2016
|HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study|
E Bonora, G Formentini, F Calcaterra, S Lombardi, F Marini, L Zenari, ...
Diabetes care 25 (7), 1135-1141, 2002
|25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey|
J Kendrick, G Targher, G Smits, M Chonchol
Atherosclerosis 205 (1), 255-260, 2009
|Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease|
G Targher, L Bertolini, R Padovani, S Rodella, G Zoppini, L Zenari, ...
Diabetes care 29 (6), 1325-1330, 2006
|Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients|
G Targher, L Bertolini, S Rodella, R Tessari, L Zenari, G Lippi, G Arcaro
Diabetes care 30 (8), 2119-2121, 2007
|Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?|
G Targher, F Marra, G Marchesini
Diabetologia 51 (11), 1947-1953, 2008
|Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease|
G Targher, L Bertolini, L Scala, M Cigolini, L Zenari, G Falezza, G Arcaro
Nutrition, Metabolism and Cardiovascular Diseases 17 (7), 517-524, 2007
|Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases|
LA Adams, QM Anstee, H Tilg, G Targher
Gut 66 (6), 1138-1153, 2017
|Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and …|
S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ...
Journal of gastroenterology and hepatology 31 (5), 936-944, 2016
|The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study|
E Bonora, G Targher, G Formentini, F Calcaterra, S Lombardi, F Marini, ...
Diabetic Medicine 21 (1), 52-58, 2004
|Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients|
M Cigolini, MP Iagulli, V Miconi, M Galiotto, S Lombardi, G Targher
Diabetes care 29 (3), 722-724, 2006